Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1991 Apr;54(4):285–287. doi: 10.1136/jnnp.54.4.285

The idiopathic inflammatory myopathies and their treatment.

J Walton
PMCID: PMC488478  PMID: 2056312

Full text

PDF
285

Images in this article

287Image
on p.287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol. 1984 Aug;16(2):193–208. doi: 10.1002/ana.410160206. [DOI] [PubMed] [Google Scholar]
  2. Arahata K., Engel A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol. 1986 Feb;19(2):112–125. doi: 10.1002/ana.410190203. [DOI] [PubMed] [Google Scholar]
  3. Bennington J. L., Dau P. C. Patients with polymyositis and dermatomyositis who undergo plasmapheresis therapy. Pathologic findings. Arch Neurol. 1981 Sep;38(9):553–560. doi: 10.1001/archneur.1981.00510090047005. [DOI] [PubMed] [Google Scholar]
  4. Bunch T. W. Prednisone and azathioprine for polymyositis: long-term followup. Arthritis Rheum. 1981 Jan;24(1):45–48. doi: 10.1002/art.1780240107. [DOI] [PubMed] [Google Scholar]
  5. Carpenter S., Karpati G. The major inflammatory myopathies of unknown cause. Pathol Annu. 1981;16(Pt 2):205–237. [PubMed] [Google Scholar]
  6. Cherin P., Herson S., Wechsler B., Piette J. C., Bletry O., Ziza J. M., Degennes C., Godeau P. Intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet. 1990 Jul 14;336(8707):116–116. doi: 10.1016/0140-6736(90)91630-s. [DOI] [PubMed] [Google Scholar]
  7. Chou S. M. Inclusion body myositis: a chronic persistent mumps myositis? Hum Pathol. 1986 Aug;17(8):765–777. doi: 10.1016/s0046-8177(86)80197-6. [DOI] [PubMed] [Google Scholar]
  8. Cumming W. J., Weiser R., Teoh R., Hudgson P., Walton J. N. Localised nodular myositis: a clinical and pathological variant of polymyositis. Q J Med. 1977 Oct;46(184):531–546. [PubMed] [Google Scholar]
  9. De Visser M., Emslie-Smith A. M., Engel A. G. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci. 1989 Dec;94(1-3):181–192. doi: 10.1016/0022-510x(89)90228-1. [DOI] [PubMed] [Google Scholar]
  10. Emslie-Smith A. M., Engel A. G. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol. 1990 Apr;27(4):343–356. doi: 10.1002/ana.410270402. [DOI] [PubMed] [Google Scholar]
  11. Engel A. G., Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol. 1986 Jul;17(7):704–721. doi: 10.1016/s0046-8177(86)80180-0. [DOI] [PubMed] [Google Scholar]
  12. Engel W. K., Lichter A. S., Galdi A. P. Polymyositis: remarkable response to total body irradiation. Lancet. 1981 Mar 21;1(8221):658–658. doi: 10.1016/s0140-6736(81)91567-1. [DOI] [PubMed] [Google Scholar]
  13. Grezard O., Lebranchu Y., Birmele B., Sharobeem R., Nivet H., Bagros P. Cyclosporin-induced muscular toxicity. Lancet. 1990 Jan 20;335(8682):177–177. doi: 10.1016/0140-6736(90)90057-c. [DOI] [PubMed] [Google Scholar]
  14. Kamm M. A., Dennett X., Byrne E. Relapsing eosinophilic myositis--a cause of pseudothrombophlebitis in an alcoholic. J Rheumatol. 1987 Aug;14(4):831–834. [PubMed] [Google Scholar]
  15. Lakhanpal S., Duffy J., Engel A. G. Eosinophilia associated with perimyositis and pneumonitis. Mayo Clin Proc. 1988 Jan;63(1):37–41. doi: 10.1016/s0025-6196(12)62663-9. [DOI] [PubMed] [Google Scholar]
  16. Layzer R. B., Shearn M. A., Satya-Murti S. Eosinophilic polymyositis. Ann Neurol. 1977 Jan;1(1):65–71. doi: 10.1002/ana.410010106. [DOI] [PubMed] [Google Scholar]
  17. Lotz B. P., Engel A. G., Nishino H., Stevens J. C., Litchy W. J. Inclusion body myositis. Observations in 40 patients. Brain. 1989 Jun;112(Pt 3):727–747. doi: 10.1093/brain/112.3.727. [DOI] [PubMed] [Google Scholar]
  18. Nishino H., Engel A. G., Rima B. K. Inclusion body myositis: the mumps virus hypothesis. Ann Neurol. 1989 Mar;25(3):260–264. doi: 10.1002/ana.410250309. [DOI] [PubMed] [Google Scholar]
  19. Serratrice G., Pellissier J. F., Cros D., Gastaut J. L., Brindisi G. Relapsing eosinophilic perimyositis. J Rheumatol. 1980 Mar-Apr;7(2):199–205. [PubMed] [Google Scholar]
  20. Smith B. E., Dyck P. J. Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Neurology. 1990 Jul;40(7):1035–1040. doi: 10.1212/wnl.40.7.1035. [DOI] [PubMed] [Google Scholar]
  21. Whitaker J. N., Engel W. K. Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med. 1972 Feb 17;286(7):333–338. doi: 10.1056/NEJM197202172860701. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES